The results revealed that the OCT1 genotype was a determinant of the insulin response to metformin in PCOS patients with no variants or one variant, although there was lack of the appropriate value for the area under the curve (AUC) of glucose in the OGTT at baseline and at the end of the treatment. This evidence concerns the gene INS and polycystic ovary syndrome.